Adult vaccination against respiratory infections in Egypt: a review of expert opinions

References

• Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis An Off Publ Infect Dis Soc Am. 2007 Mar;44(Suppl 2):S27–72. doi: 10.1086/511159
   PubMed Web of Science ®Google Scholar
• File TM. Community-acquired pneumonia. Lancet (London, England). 2003 Dec;362(9400):1991–2001. doi: 10.1016/S0140-6736(03)15021-0
   PubMed Web of Science ®Google Scholar
• File TM, Marrie TJ. Burden of community-acquired pneumonia in north American adults. Postgrad Med [Internet]. 2010 Mar 1;122(2):130–141. Available from 10.3810/pgm.2010.03.2130
   PubMed Web of Science ®Google Scholar
• Ramirez JA, Wiemken TL, Peyrani P, et al. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis An Off Publ Infect Dis Soc Am. 2017 Nov;65(11):1806–1812. doi: 10.1093/cid/cix647
   PubMed Web of Science ®Google Scholar
• Xu J, Murphy SL, Kochanek KD, Arias E. Deaths: final data for 2019 [internet], editor. (U.S.) NC for HS. Vol. 70. Hyattsville (MD): National Vital Statistics Reports. Available from: https://stacks.cdc.gov/view/cdc/106058
   Google Scholar
• Pfuntner A, Wier LM, Steiner C. Costs for hospital stays in the United States. Rockville (MD): Agency for Healthcare Research and Quality; 2010.
   Google Scholar
• Bonafede MM, Suaya JA, Wilson KL, et al. Incidence and cost of CAP in a large working-age population. Am J Manag Care. 2012 Jul;18(7):380–387.
   PubMed Web of Science ®Google Scholar
• Colice GL, Morley MA, Asche C, et al. Treatment costs of community-acquired pneumonia in an employed population. Chest. 2004 Jun;125(6):2140–2145. doi: 10.1378/chest.125.6.2140
   PubMed Web of Science ®Google Scholar
• Violi F, Cangemi R, Falcone M, et al. Cardiovascular complications and short-term mortality risk in community-acquired pneumonia. Clin Infect Dis An Off Publ Infect Dis Soc Am. 2017 Jun;64(11):1486–1493. doi: 10.1093/cid/cix164
   PubMed Web of Science ®Google Scholar
• Eurich DT, Marrie TJ, Minhas-Sandhu JK, et al. Risk of heart failure after community acquired pneumonia: prospective controlled study with 10 years of follow-up. BMJ. 2017 Feb;356:j413. doi: 10.1136/bmj.j413
   PubMedGoogle Scholar
• Ramirez J, Aliberti S, Mirsaeidi M, et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis An Off Publ Infect Dis Soc Am. 2008 Jul;47(2):182–187. doi: 10.1086/589246
   PubMed Web of Science ®Google Scholar
• Bruns AHW, Oosterheert JJ, Cucciolillo MC, et al. Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2011 May;17(5):763–768. doi: 10.1111/j.1469-0691.2010.03296.x
   PubMed Web of Science ®Google Scholar
• Kandeel A, Fahim M, Deghedy O, Roshdy WH, Khalifa MK, El SR, et al. Resurgence of influenza and respiratory syncytial virus in Egypt following two years of decline during the COVID-19 pandemic: outpatient clinic survey of infants and children, October 2022. BMC Public Health [Internet]. 2023;23(1):1067. doi: 10.1186/s12889-023-15880-9
   PubMed Web of Science ®Google Scholar
• El-Sokkary RH, Ramadan RA, El-Shabrawy M, et al. Community acquired pneumonia among adult patients at an Egyptian university hospital: bacterial etiology, susceptibility profile and evaluation of the response to initial empiric antibiotic therapy. Infect Drug Resist. 2018;11:2141–2150. doi: 10.2147/IDR.S182777
   PubMed Web of Science ®Google Scholar
• Khalil MM, Abdel Dayem AM, Farghaly AAAH, Shehata HM. Pattern of community and hospital acquired pneumonia in Egyptian military hospitals. Egyptian J Chest DisTuberc [Internet]. 2013;62(1):9–16. Available from: https://www.sciencedirect.com/science/article/pii/S0422763813000046
   Google Scholar
• Balkhy HH, Cunningham G, Chew FK, et al. Hospital- and community-acquired infections: a point prevalence and risk factors survey in a tertiary care center in Saudi Arabia. Int J Infect Dis [Internet]. 2006;10(4):326–333. doi: 10.1016/j.ijid.2005.06.013
   PubMed Web of Science ®Google Scholar
• Al-Muhairi S, Zoubeidi T, Ellis M, et al. Demographics and microbiological profile of pneumonia in United Arab Emirates. Monaldi arch chest dis = arch monaldi per le mal del torace. Monaldi Archives For Chest Disease. 2006 Mar;65(1):13–18. doi: 10.4081/monaldi.2006.580
   PubMedGoogle Scholar
• Hanssens Y, Ismaeil BB, Kamha AA, et al. Antibiotic prescribing pattern in a medical intensive care unit in Qatar. Saudi Med J. 2005 Aug;26(8):1269–1276.
   PubMed Web of Science ®Google Scholar
• Al-Muhairi SS, Zoubeidi TA, Ellis ME, et al. Risk factors predicting outcome in patients with pneumonia in Al-ain, United Arab Emirates. Saudi Med J. 2006 Jul;27(7):1044–1048.
   PubMed Web of Science ®Google Scholar
• Jain S, Self WH, Wunderink RG, et al. Community-acquired pneumonia requiring hospitalization among U.S adults. N Engl J Med. 2015 Jul;373(5):415–427. doi: 10.1056/NEJMoa1500245
   PubMed Web of Science ®Google Scholar
• Torres A, Peetermans WE, Viegi G, et al. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013 Nov;68(11):1057–1065. doi: 10.1136/thoraxjnl-2013-204282
   PubMed Web of Science ®Google Scholar
• Almirall J, Bolíbar I, Balanzó X, et al. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. Eur Respir J. 1999 Feb;13(2):349–355. doi: 10.1183/09031936.99.13234999
   PubMed Web of Science ®Google Scholar
• Shaaban LH. Dilemma of community-acquired pneumonia. Egypt J Chest Dis Tuberc [Internet]. 2019;68(1). Available from 1. doi: 10.4103/ejcdt.ejcdt_189_18
   Web of Science ®Google Scholar
• Memoli MJ, Athota R, Reed S, et al. The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis An Off Publ Infect Dis Soc Am. 2014 Jan;58(2):214–224. doi: 10.1093/cid/cit725
   PubMed Web of Science ®Google Scholar
• Burk M, El-Kersh K, Saad M, et al. Viral infection in community-acquired pneumonia: a systematic review and meta-analysis. Eur Respir Rev An Off J Eur Respir Soc. 2016 Jun;25(140):178–188. doi: 10.1183/16000617.0076-2015
   PubMed Web of Science ®Google Scholar
• Wu X, Wang Q, Wang M, et al. Incidence of respiratory viral infections detected by PCR and real-time PCR in adult patients with community-acquired pneumonia: a meta-analysis. Respiration. 2015;89(4):343–352. doi: 10.1159/000369561
   PubMed Web of Science ®Google Scholar
• Alimi Y, Lim WS, Lansbury L, et al. Systematic review of respiratory viral pathogens identified in adults with community-acquired pneumonia in Europe. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2017 Oct;95:26–35. doi: 10.1016/j.jcv.2017.07.019
   Web of Science ®Google Scholar
• Johansson N, Kalin M, Tiveljung-Lindell A, et al. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis An Off Publ Infect Dis Soc Am. 2010 Jan;50(2):202–209. doi: 10.1086/648678
   PubMed Web of Science ®Google Scholar
• Marrie TJ, Poulin-Costello M, Beecroft MD, et al. Etiology of community-acquired pneumonia treated in an ambulatory setting. Respir med. 2005 Jan;99(1):60–65. doi: 10.1016/j.rmed.2004.05.010
   PubMed Web of Science ®Google Scholar
• Cillóniz C, Ewig S, Polverino E, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax. 2011 Apr;66(4):340–346. doi: 10.1136/thx.2010.143982
   PubMed Web of Science ®Google Scholar
• Restrepo MI, Mortensen EM, Velez JA, et al. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest. 2008 Mar;133(3):610–617. doi: 10.1378/chest.07-1456
   PubMed Web of Science ®Google Scholar
• Grohskopf LA, Blanton LH, Ferdinands JM, et al. Prevention and Control of Seasonal Influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza season. MMWR Morb Mortal Wkly Rep. 2022 Aug;71(1):1–28. doi: 10.15585/mmwr.rr7101a1
   PubMed Web of Science ®Google Scholar
• Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2011 Aug;60(33):1128–1132.
   PubMedGoogle Scholar
• Tomczyk S, Bennett NM, Stoecker C, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2014 Sep;63(37):822–825.
   PubMed Web of Science ®Google Scholar
• Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012 Oct;61(40):816–819. doi: 10.1111/ajt.12073
   PubMedGoogle Scholar
• Kobayashi M, Farrar JL, Gierke R, et al. Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. Adults: updated recommendations of the advisory committee on immunization practices - United States, 2022. MMWR Morb Mortal Wkly Rep. 2022 Jan;71(4):109–117. doi: 10.15585/mmwr.mm7104a1
   PubMed Web of Science ®Google Scholar
• Rovin BH, Adler SG, Barratt J, et al. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Vol. 100. United States: Kidney international; 2021. p. S1–276.
   Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37(27):2129–2200m. doi: 10.1093/eurheartj/ehw128
   PubMed Web of Science ®Google Scholar
• Esposito S, Bonanni P, Maggi S, et al. Recommended immunization schedules for adults: clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and immunological disorders (WAidid). Hum Vaccin Immunother. 2016 Jul;12(7):1777–1794. doi: 10.1080/21645515.2016.1150396
   PubMed Web of Science ®Google Scholar
• Venkatesan P. First RSV vaccine approvals. Lancet Microbe [Internet]. 2023 Aug 1;4(8):e577. Available from 10.1016/S2666-5247(23)00195-7
   PubMedGoogle Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American heart Association Task Force on practice guidelines. Circulation. 2013 Oct;128(16):1810–1852. doi: 10.1161/CIR.0b013e31829e8807
   PubMed Web of Science ®Google Scholar
• Davis MM, Taubert K, Benin AL, et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. J Am Coll Cardiol. 2006 Oct;48(7):1498–1502. doi: 10.1016/j.jacc.2006.09.004
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Professional Practice Committee. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2022. Diabetes Care. 2022 Jan;45(Suppl 1):S46–59. doi: 10.2337/dc22-S004
   PubMedGoogle Scholar
• Furer V, Rondaan C, Heijstek MW, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020 Jan;79(1):39–52. doi: 10.1136/annrheumdis-2019-215882
   PubMed Web of Science ®Google Scholar
• Liu BC, McIntyre P, Kaldor JM, et al. Pertussis in older adults: prospective study of risk factors and morbidity. Clin Infect Dis An Off Publ Infect Dis Soc Am. 2012 Dec;55(11):1450–1456. doi: 10.1093/cid/cis627
   PubMed Web of Science ®Google Scholar
• Keitel WA, Muenz LR, Decker MD, et al. A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization. J Infect Dis. 1999 Aug;180(2):397–403. doi: 10.1086/314869
   PubMed Web of Science ®Google Scholar
• Demicheli V, Jefferson T, Ferroni E, et al. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2018 Feb;2(2):CD001269. doi: 10.1002/14651858.CD004879.pub5
   PubMedGoogle Scholar
• Ferdinands JM, Thompson MG, Blanton L, et al. Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research. Vaccine. 2021 Jun;39(28):3678–3695. doi: 10.1016/j.vaccine.2021.05.011
   PubMed Web of Science ®Google Scholar
• Molinari NAM, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007 Jun;25(27):5086–5096. doi: 10.1016/j.vaccine.2007.03.046
   PubMed Web of Science ®Google Scholar
• McLaughlin JM, McGinnis JJ, Tan L, et al. Estimated human and economic burden of four major adult vaccine-preventable diseases in the United States, 2013. J Prim Prev. 2015 Aug;36(4):259–273. doi: 10.1007/s10935-015-0394-3
   PubMed Web of Science ®Google Scholar
• Allam A, Salah K, Shokry D, Abdulla I, Yehia S, Hammad N. The incidence of mycoplasma pneumoniae in community acquired pneumonia among children: one centre study. Microbes Infect dis [Internet]. 2020;1(3):182–189. Available from: https://mid.journals.ekb.eg/article_91921.html
   Google Scholar
• Bizri AR, Althaqafi A, Kaabi N, et al. The burden of invasive vaccine-preventable diseases in adults in the Middle East and North Africa (MENA) region. Infect Dis Ther [Internet]. 2021;10(2):663–685. doi: 10.1007/s40121-021-00420-y
   PubMed Web of Science ®Google Scholar
• Shibl AM, Memish ZA, Ibrahim E, et al. Burden of adult community-acquired pneumonia in the Middle East/North Africa region. Rev Res Med Microbiol. 2010;21(1):11–20. doi: 10.1097/MRM.0b013e3283377af7
   Web of Science ®Google Scholar
• Menéndez R, Cremades MJ, Martínez-Moragón E, et al. Duration of length of stay in pneumonia: influence of clinical factors and hospital type. Eur Respir J. 2003 Oct;22(4):643–648. doi: 10.1183/09031936.03.00026103
   PubMed Web of Science ®Google Scholar
• Kaysar M, Augustine T, Jim L, et al. Predictors of length of stay between the young and aged in hospitalized community-acquired pneumonia patients. Geriatr Gerontol Int. 2008 Dec;8(4):227–233. doi: 10.1111/j.1447-0594.2008.00480.x
   PubMed Web of Science ®Google Scholar
• Masotti L, Ceccarelli E, Cappelli R, et al. Length of hospitalization in elderly patients with community-acquired pneumonia. Aging. 2000 Feb;12(1):35–41. doi: 10.1007/BF03339826
   PubMedGoogle Scholar
• Ashrafi-Asgarabad A, Bokaie S, Razmyar J, et al. The burden of lower respiratory infections and their underlying etiologies in the Middle East and North Africa region, 1990–2019: results from the Global burden of disease Study 2019. BMC Pulm Med [Internet]. 2023;23(1):1–14. doi: 10.1186/s12890-022-02301-7
   PubMed Web of Science ®Google Scholar
• Miravalle A, Biller J, Schnitzler E, et al. Neurological complications following vaccinations. Neurol Res [Internet]. 2010 Apr 1;32(3):285–292. doi: 10.1179/016164110X12645013515214
   PubMed Web of Science ®Google Scholar
• Chung JY, Lee SJ, Shin BS, et al. Myasthenia gravis following human papillomavirus vaccination: a case report. BMC neurol. 2018 Dec;18(1):222. doi: 10.1186/s12883-018-1233-y
   PubMed Web of Science ®Google Scholar
• Chatterjee A, Chakravarty A. Neurological complications following COVID-19 vaccination. Curr Neurol Neurosci Rep. 2023 Jan;23(1):1–14. doi: 10.1007/s11910-022-01247-x
   PubMed Web of Science ®Google Scholar
• Kobayashi M. Considerations for age-based and risk-based use of PCV15 and PCV20 among U.S. adults and proposed policy options [internet], editor. (U.S.) NC for I and RD. Vol. 202113. Atlanta (GA): ACIP meeting Pneumococcal Vaccines. Available from: https://stacks.cdc.gov/view/cdc/110908
   Google Scholar
• Bass AR, Chakravarty E, Akl EA, et al. American College of Rheumatology Guideline for Vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Care Res (Hoboken). 2023 Mar;75(3):449–464. doi: 10.1002/acr.25045
   PubMed Web of Science ®Google Scholar
• Behrouzi B, Araujo Campoverde MV, Liang K, et al. Influenza vaccination to reduce cardiovascular morbidity and mortality in patients with COVID-19: JACC state-of-the-art review. J Am Coll Cardiol. 2020 Oct;76(15):1777–1794. doi: 10.1016/j.jacc.2020.08.028
   PubMed Web of Science ®Google Scholar
• Toback S, Galiza E, Cosgrove C, et al. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Lancet Respir Med [Internet]. 2022 Feb 1;10(2):167–179. doi: 10.1016/S2213-2600(21)00409-4
   PubMed Web of Science ®Google Scholar
• McLean HQ, Petrie JG, Hanson KE, et al. Interim estimates of 2022-23 seasonal influenza vaccine effectiveness - Wisconsin, October 2022-February 2023. MMWR Morb Mortal Wkly Rep. 2023 Feb;72(8):201–205. doi: 10.15585/mmwr.mm7208a1
   PubMed Web of Science ®Google Scholar
• Moltó A, Etcheto A, van der Heijde D, et al. Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis. 2016 Jun;75(6):1016–1023. doi: 10.1136/annrheumdis-2015-208174
   PubMed Web of Science ®Google Scholar
• Dougados M, Soubrier M, Antunez A, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2014 Jan;73(1):62–68. doi: 10.1136/annrheumdis-2013-204223
   PubMed Web of Science ®Google Scholar
• Lord JM. The effect of ageing of the immune system on vaccination responses. Hum Vaccin Immunother. 2013 Jun;9(6):1364–1367. doi: 10.4161/hv.24696
   PubMed Web of Science ®Google Scholar
• Zhang R, Lu X, Wu W, et al. Why do patients follow physicians’ advice? The influence of patients’ regulatory focus on adherence: an empirical study in China. BMC Health Serv Res [Internet]. 2019;19(1):301. doi: 10.1186/s12913-019-4127-9
   PubMedGoogle Scholar
• Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med. 2008 Jul;121(7 Suppl 2):S28–35. doi: 10.1016/j.amjmed.2008.05.005
   PubMed Web of Science ®Google Scholar
• MacDougall DM, Halperin BA, MacKinnon-Cameron D, et al. The challenge of vaccinating adults: attitudes and beliefs of the Canadian public and healthcare providers. BMJ Open [Internet]. 2015 Sep 1;5(9):e009062. Available from: http://bmjopen.bmj.com/content/5/9/e009062.abstract
   PubMed Web of Science ®Google Scholar